Werbung
Werbung
DARE
Dare Bioscience, Inc. Common Stock
1.99
USDGesponsert
-0.08
-4.11%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
2.01
+0.02
+1.26%
DARE Ergebnisberichte
Positives Überraschungsverhältnis
DARE übertreffen die 23 der letzten 36Schätzungen.
64%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$383.26K
/-$0.37
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+19063.25%
/+32.14%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-698.85%
/-43.08%
Dare Bioscience, Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, DARE reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.36 USD, resulting in a 23.03% surprise. Revenue reached 2.00 tausend, compared to an expected 9.95 tausend, with a -79.89% difference. The market reacted with a -1.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.37 USD, with revenue projected to reach 383.26 tausend USD, implying an increase of 32.14% EPS, and increase of 19063.25% in Revenue from the last quarter.
FAQ
What were Dare Bioscience, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dare Bioscience, Inc. Common Stock reported EPS of -$0.28, beating estimates by 23.03%, and revenue of $2.00K, -79.89% below expectations.
How did the market react to Dare Bioscience, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.59%, changed from $1.89 before the earnings release to $1.86 the day after.
When is Dare Bioscience, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for Dare Bioscience, Inc. Common Stock's next earnings report?
Based on 6
analysts, Dare Bioscience, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of $383.26K for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung